Phase I Trial to Investigate Cafusertib Hydrochloride in Combination With Low Dose Cytarabine in Chinese Patients With Acute Myeloid Leukaemia (AML)
Clinical trial NCT02140606 · UNKNOWN
Trial details
- NCT number
- NCT02140606
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-12-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.